ATE142875T1 - Methode zur behandlung von haarausfall - Google Patents

Methode zur behandlung von haarausfall

Info

Publication number
ATE142875T1
ATE142875T1 AT93202226T AT93202226T ATE142875T1 AT E142875 T1 ATE142875 T1 AT E142875T1 AT 93202226 T AT93202226 T AT 93202226T AT 93202226 T AT93202226 T AT 93202226T AT E142875 T1 ATE142875 T1 AT E142875T1
Authority
AT
Austria
Prior art keywords
hair loss
treating hair
alopecia
complexes
medicament
Prior art date
Application number
AT93202226T
Other languages
English (en)
Inventor
Benjamin Sredni
Michael Albeck
Original Assignee
Benjamin Sredni
Michael Albeck
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Benjamin Sredni, Michael Albeck filed Critical Benjamin Sredni
Application granted granted Critical
Publication of ATE142875T1 publication Critical patent/ATE142875T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0491—Sugars, nucleosides, nucleotides, oligonucleotides, nucleic acids, e.g. DNA, RNA, nucleic acid aptamers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Optics & Photonics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Apparatuses For Bulk Treatment Of Fruits And Vegetables And Apparatuses For Preparing Feeds (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
AT93202226T 1992-08-13 1993-07-28 Methode zur behandlung von haarausfall ATE142875T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/929,681 US5262149A (en) 1992-08-13 1992-08-13 Method of treating or preventing alopecia

Publications (1)

Publication Number Publication Date
ATE142875T1 true ATE142875T1 (de) 1996-10-15

Family

ID=25458271

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93202226T ATE142875T1 (de) 1992-08-13 1993-07-28 Methode zur behandlung von haarausfall

Country Status (7)

Country Link
US (2) US5262149A (de)
EP (1) EP0583026B1 (de)
AT (1) ATE142875T1 (de)
DE (1) DE69304843T2 (de)
DK (1) DK0583026T3 (de)
ES (1) ES2093357T3 (de)
GR (1) GR3021813T3 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5262149A (en) * 1992-08-13 1993-11-16 Benjamin Sredni Method of treating or preventing alopecia
GB9315126D0 (en) * 1993-07-21 1993-09-01 Philips Electronics Uk Ltd Opto-electronic memory systems
US5654328A (en) * 1994-12-15 1997-08-05 Sredni; Benjamin Method and composition for reducing tumor development with a combination of platinum and tellurium or selenium compounds
ATE306927T1 (de) * 1994-12-15 2005-11-15 Baker Norton Pharma Verfahren und mittel zur verminderung der tumorentwicklung mittels einer kombination aus einer taxanverbindung und einer tellur und/oder selenverbindung
US20050019425A1 (en) * 2001-11-07 2005-01-27 Shiguang Yu Composition and method
US20060258697A1 (en) * 2003-05-13 2006-11-16 Rustum Youcef M Method of augmenting the antitumor activity of anticancer agents
CA2530634A1 (en) * 2003-06-12 2004-12-23 Menachem Rubinstein Methods of treating obesity and related disorders using tellurium and selenium compounds
US7534818B1 (en) * 2003-09-15 2009-05-19 Health Research, Inc. Method of reducing alopecia and bladder toxicity of cyclophosphamide
CA2550459C (en) * 2003-12-18 2009-12-15 Biomas, Ltd. Tellurium derivatives for prevention and treatment of neurodegenerative processes
US20080260770A1 (en) * 2004-09-17 2008-10-23 Biomas Ltd. Use of Tellurium Compounds as Adjuvants
AU2005283719A1 (en) * 2004-09-17 2006-03-23 Biomas Ltd. Compositions and methods for inducing hair growth
US9925218B2 (en) * 2013-07-17 2018-03-27 Pilogics L.P. Composition, method and kit for formation of galvanic cells on the skin

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4761490A (en) * 1985-03-15 1988-08-02 Bar-Ilan University Organic derivatives of tellurium and selenium and their use to stimulate cytokine production
US5271925A (en) * 1990-03-09 1993-12-21 Benjamin Sredni Method for protecting against the effects of radiation which is based on the administration of a selenium or tellurium based compound
US5262149A (en) * 1992-08-13 1993-11-16 Benjamin Sredni Method of treating or preventing alopecia

Also Published As

Publication number Publication date
EP0583026B1 (de) 1996-09-18
EP0583026A1 (de) 1994-02-16
DK0583026T3 (de) 1997-02-24
GR3021813T3 (en) 1997-02-28
DE69304843T2 (de) 1997-04-10
DE69304843D1 (de) 1996-10-24
US5262149A (en) 1993-11-16
ES2093357T3 (es) 1996-12-16
US6552089B1 (en) 2003-04-22

Similar Documents

Publication Publication Date Title
ATE184792T1 (de) 2-bromomelatonin zur behandlung von schlafstörungen
ATE213411T1 (de) Verwendung von phenserin zur herstellung von medikamenten zur behandlung von kognitiven störungen
ATE224714T1 (de) Behandlung von tinnitus mit neuroprotektiven wirkstoffen
DE69532804D1 (de) Verwendung von hemmern des maillard-reaktion zur behandlung von krankheiten zufolge amyloidosis
ATE145136T1 (de) Verwendung von ketoconazol und ein retinoid zur behandlung der akne vulgaris
DE69010162D1 (de) Zusammensetzung zur Behandlung von Entzündung.
ATE142875T1 (de) Methode zur behandlung von haarausfall
ATE137965T1 (de) Verwendung von tomoxetine zur behandlung von funktionsstörungen der niedrigen harnwege
DE69424777D1 (de) 3,4-diarylchromane zur behandlung von dermatitis
DK0668077T3 (da) Produkter, som indeholder G-CSF og TNF-bindende protein
DE68917433D1 (de) Verfahren zur behandlung von asbest sowie asbestbehandlungsmittel.
DE69800859D1 (de) Verwendung von Moxonidin zur Behandlung neuropathischer Schmerzen
ATE183097T1 (de) Zusammensetzung und methode zur behandlung von störungen in form von depigmentierung
ATE222491T1 (de) Melatonin-derivate zur verwendung in der behandlung von schlafstörungen
ATE88084T1 (de) Verwendung eines gemisches zur behandlung der alopezie.
ATE294584T1 (de) Verwendung von desoxypeganin zur behandlung von alzheimerischer demenz
ATE204476T1 (de) Verwendung von 3,5-diamino-6-(2,3-dichlorophenyl)-1,2,4-triazi e zur herstrllung eines medikaments zur behandlung von bestimmten schmerzen und ödem
ATE359808T1 (de) Verwendung von sarp-1 zur behandlung und/oder vorbeugung von scleroderma
ATE137967T1 (de) Verwendung von ketorolac zur behandlung von periodontitis
DE69300037D1 (de) Verwendung von Bucillamin zur Herstellung eines Arzneimittels zur Behandlung von Cystinuria.
DE69906701D1 (de) Topische verwendung von loperamid zur behandlung mikrobieller infektionen
DE69004529D1 (de) Verwendung von Sertralin zur Behandlung von Abhängigkeiten von chemischen Stoffen.
DE69307702D1 (de) Verwendung von (e) - 2 - (p -fluorophenethyl)- 3 - fluoroallylamine zur behandlung der alzheimerschen krankheit
ATE178336T1 (de) Verwendung einer therapeutischen zusammensetzung zur behandlung von bronchitis
DE59709081D1 (de) Verwendung von Bradykinin-Antagonisten zur Herstellung von Arzneimitteln zur Behandlung und Prävention der Alzheimer'schen Krankheit

Legal Events

Date Code Title Description
REN Ceased due to non-payment of the annual fee